
Willow Biosciences Inc
TSX:WLLW

Intrinsic Value
The intrinsic value of one
WLLW
stock under the Base Case scenario is
0.09
CAD.
Compared to the current market price of 0.18 CAD,
Willow Biosciences Inc
is
Overvalued by 53%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Willow Biosciences Inc
Loading...
Fundamental Analysis


Revenue & Expenses Breakdown
Willow Biosciences Inc
Balance Sheet Decomposition
Willow Biosciences Inc
Current Assets | 2.3m |
Cash & Short-Term Investments | 182k |
Receivables | 7k |
Other Current Assets | 2.1m |
Non-Current Assets | 17k |
PP&E | 17k |
Free Cash Flow Analysis
Willow Biosciences Inc
CAD | |
Free Cash Flow | CAD |
Earnings Waterfall
Willow Biosciences Inc
Revenue
|
6.4m
CAD
|
Operating Expenses
|
-9.5m
CAD
|
Operating Income
|
-3.1m
CAD
|
Other Expenses
|
-1m
CAD
|
Net Income
|
-4.1m
CAD
|
WLLW Profitability Score
Profitability Due Diligence
Willow Biosciences Inc's profitability score is 20/100. The higher the profitability score, the more profitable the company is.

Score
Willow Biosciences Inc's profitability score is 20/100. The higher the profitability score, the more profitable the company is.
WLLW Solvency Score
Solvency Due Diligence
Willow Biosciences Inc's solvency score is 42/100. The higher the solvency score, the more solvent the company is.

Score
Willow Biosciences Inc's solvency score is 42/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
WLLW Price Targets Summary
Willow Biosciences Inc
Dividends
Current shareholder yield for WLLW is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
WLLW
stock under the Base Case scenario is
0.09
CAD.
Compared to the current market price of 0.18 CAD,
Willow Biosciences Inc
is
Overvalued by 53%.